Cutaneous Adverse Effects of EGFR Therapy in Breast Cancer Treatment
ABSTRACT Breast cancer is among the most common cancers in U.S. women. Epidermal growth factor receptor inhibitors (EGFRIs) target pathways driving tumor growth but frequently cause dermatologic toxicities that impact quality of life and treatment adherence. This review summarizes the clinical featu...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Wiley
2025-12-01
|
| Schriftenreihe: | Clinical and Translational Science |
| Schlagworte: | |
| Online-Zugang: | https://doi.org/10.1111/cts.70432 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|